Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
811.33
921.93
819.37
665.90
559.56
450.06
508.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
811.33
921.93
819.37
665.90
559.56
450.06
508.04
Raw Material Cost
462.34
585.46
528.35
406.10
340.62
245.60
235.54
Purchase of Finished goods
1.69
2.61
0.00
0.00
0.00
0.00
0.17
(Increase) / Decrease In Stocks
61.85
-43.85
-43.89
-21.48
-27.06
-17.09
7.58
Employee Cost
91.47
86.36
69.64
65.35
63.28
67.11
84.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
152.85
174.17
154.59
132.31
133.11
104.67
205.49
Total Expenditure (Excl Depreciation)
770.20
804.75
708.69
582.28
509.95
400.28
533.52
Operating Profit (PBDIT) excl Other Income
41.13
117.18
110.68
83.62
49.61
49.78
-25.48
Other Income
35.17
27.47
30.86
19.43
9.00
15.23
24.49
Operating Profit (PBDIT)
76.30
144.65
141.54
103.05
58.61
65.01
-0.99
Interest
13.26
14.54
16.35
32.23
32.01
51.34
4.16
Exceptional Items
-6.57
0.00
0.00
-6.78
0.00
0.00
0.00
Gross Profit (PBDT)
56.47
130.11
125.19
110.03
26.60
13.67
-5.15
Depreciation
35.45
34.55
33.24
54.79
87.02
108.92
125.92
Profit Before Tax
21.02
95.56
91.95
55.25
-60.42
-95.25
-131.07
Tax
-0.19
-0.19
-3.12
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
21.21
95.76
95.06
55.25
-60.42
-95.25
-131.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
-6.78
58.47
-21.28
0.00
Net Profit
21.21
95.76
95.06
48.47
-1.95
-116.53
-131.07
Share in Profit of Associates
-0.66
3.90
-2.90
-2.15
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.55
99.66
92.17
46.32
-1.95
-116.53
-131.07
Equity Capital
50.72
50.72
50.72
40.82
40.82
40.82
40.82
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,237.07
1,216.57
1,118.75
647.83
0.00
612.09
983.54
Earnings per share (EPS)
4.05
19.65
18.17
11.35
-0.48
-28.55
-32.11
Diluted Earnings per share
4.05
19.65
19.06
11.35
-0.48
-28.55
-32.11
Operating Profit Margin (Excl OI)
5.07%
12.71%
13.51%
12.56%
8.87%
11.06%
-5.02%
Gross Profit Margin
6.96%
14.11%
15.28%
16.52%
4.75%
3.04%
-1.01%
PAT Margin
2.61%
10.39%
11.6%
8.3%
-10.8%
-21.16%
-25.8%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -12.00% vs 12.52% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is -79.38% vs 8.13% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -64.90% vs 5.87% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -8.80% vs -11.07% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
Compare Annual Results Of Orchid Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
811.33
1,630.02
-818.69
-50.23%
Other Operating Income
0.00
0.00
0.00
Total Operating income
811.33
1,630.02
-818.69
-50.23%
Raw Material Cost
462.34
1,005.46
-543.12
-54.02%
Purchase of Finished goods
1.69
58.33
-56.64
-97.10%
(Increase) / Decrease In Stocks
61.85
-11.00
72.85
662.27%
Employee Cost
91.47
167.20
-75.73
-45.29%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
152.85
167.11
-14.26
-8.53%
Total Expenditure (Excl Depreciation)
770.20
1,387.10
-616.90
-44.47%
Operating Profit (PBDIT) excl Other Income
41.13
242.92
-201.79
-83.07%
Other Income
35.17
7.42
27.75
373.99%
Operating Profit (PBDIT)
76.30
250.34
-174.04
-69.52%
Interest
13.26
16.90
-3.64
-21.54%
Exceptional Items
-6.57
0.00
-6.57
Gross Profit (PBDT)
56.47
233.44
-176.97
-75.81%
Depreciation
35.45
45.18
-9.73
-21.54%
Profit Before Tax
21.02
188.26
-167.24
-88.83%
Tax
-0.19
47.35
-47.54
-100.40%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
21.21
140.92
-119.71
-84.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
21.21
140.92
-119.71
-84.95%
Share in Profit of Associates
-0.66
0.00
-0.66
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.55
140.92
-120.37
-85.42%
Equity Capital
50.72
57.23
-6.51
-11.38%
Face Value
10.00
10.00
0.00
Reserves
1,237.07
1,033.57
203.50
19.69%
Earnings per share (EPS)
4.05
24.62
-20.57
-83.55%
Diluted Earnings per share
4.05
24.63
-20.58
-83.56%
Operating Profit Margin (Excl OI)
5.07%
14.90%
0.00
-9.83%
Gross Profit Margin
6.96%
14.32%
0.00
-7.36%
PAT Margin
2.61%
8.65%
0.00
-6.04%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 811.33 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -12.00% vs 12.52% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 20.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -79.38% vs 8.13% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.13 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -64.90% vs 5.87% in Mar 2025
Annual - Interest
Interest 13.26 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -8.80% vs -11.07% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.07%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
